Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference
November 27, 2017 16:10 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in investor...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference
November 21, 2017 16:10 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
Sucampo to Host 2017
Sucampo to Host 2017 R&D Day on November 16 in New York
November 09, 2017 17:48 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its 2017 R&D Day...
Sucampo Reports Thir
Sucampo Reports Third Quarter 2017 Financial Results
November 01, 2017 06:30 ET | Sucampo Pharmaceuticals Inc
Company Increases 2017 Financial Guidance Based on Strong Performance Year to Date Study Results for VTS-270 for Niemann-Pick Disease Type C1 Published in The Lancet CPP-1X/sulindac Granted...
Sucampo Announces Th
Sucampo Announces Third Quarter 2017 Earnings Call
October 23, 2017 16:05 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its third quarter 2017...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation
September 28, 2017 17:34 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that the U.S. Food and Drug...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance Conference
September 27, 2017 20:43 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the company will participate in...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
September 21, 2017 08:25 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel
September 20, 2017 16:15 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the appointment of Alex Driggs to...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference
September 19, 2017 16:15 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...